Literature DB >> 12500256

Endothelial cell-matrix interactions.

Erika Iivanainen1, Veli-Matti Kähäri, Jyrki Heino, Klaus Elenius.   

Abstract

Dynamic interactions between endothelial cells and components of their surrounding extracellular matrix are necessary for the invasion, migration, and survival of endothelial cells during angiogenesis. These interactions are mediated by matrix receptors that initiate intracellular signaling cascades in response to binding to specific extracellular matrix molecules. The interactions between endothelial cells and their environment are also modulated by enzymes that degrade different matrix components and thus enable endothelial invasion. Recent reports on gene targeting in mice have confirmed the role of two classes of matrix receptors, integrins and cell surface heparan sulfate proteoglycans, and a group of matrix degrading proteolytic enzymes, matrix metalloproteinases, in angiogenesis. The significance of endothelial cell-matrix interactions is further supported by several ongoing clinical trials that analyze the effects of drugs blocking this interaction on angiogenesis-dependent growth of human tumors. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12500256     DOI: 10.1002/jemt.10238

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  28 in total

Review 1.  Liver regeneration and tumor stimulation--a review of cytokine and angiogenic factors.

Authors:  Christopher Christophi; Nadia Harun; Theodora Fifis
Journal:  J Gastrointest Surg       Date:  2008-01-08       Impact factor: 3.452

2.  Characterization of endothelial basement membrane nanotopography in rhesus macaque as a guide for vessel tissue engineering.

Authors:  Sara J Liliensiek; Paul Nealey; Christopher J Murphy
Journal:  Tissue Eng Part A       Date:  2009-09       Impact factor: 3.845

3.  Multicellular Vascularized Engineered Tissues through User-Programmable Biomaterial Photodegradation.

Authors:  Christopher K Arakawa; Barry A Badeau; Ying Zheng; Cole A DeForest
Journal:  Adv Mater       Date:  2017-07-24       Impact factor: 30.849

Review 4.  Strategies and techniques to enhance the in situ endothelialization of small-diameter biodegradable polymeric vascular grafts.

Authors:  Anthony J Melchiorri; Narutoshi Hibino; John P Fisher
Journal:  Tissue Eng Part B Rev       Date:  2013-02-13       Impact factor: 6.389

Review 5.  Current understanding of intimal hyperplasia and effect of compliance in synthetic small diameter vascular grafts.

Authors:  YeJin Jeong; Yuan Yao; Evelyn K F Yim
Journal:  Biomater Sci       Date:  2020-07-09       Impact factor: 6.843

6.  HIP/RPL29 antagonizes VEGF and FGF2 stimulated angiogenesis by interfering with HS-dependent responses.

Authors:  Sonia D'Souza; Weidong Yang; Dario Marchetti; Caroline Muir; Mary C Farach-Carson; Daniel D Carson
Journal:  J Cell Biochem       Date:  2008-12-01       Impact factor: 4.429

7.  Integrin affinity modulation in angiogenesis.

Authors:  Ganapati H Mahabeleshwar; Juhua Chen; Weiyi Feng; Payaningal R Somanath; Olga V Razorenova; Tatiana V Byzova
Journal:  Cell Cycle       Date:  2007-11-01       Impact factor: 4.534

8.  Increased expression of fibronectin and the alpha 5 beta 1 integrin in angiogenic cerebral blood vessels of mice subject to hypobaric hypoxia.

Authors:  Richard Milner; Stephanie Hung; Bernadette Erokwu; Paula Dore-Duffy; Joseph C LaManna; Gregory J del Zoppo
Journal:  Mol Cell Neurosci       Date:  2008-02-13       Impact factor: 4.314

9.  Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative study.

Authors:  Alejandro D Ricart; Anthony W Tolcher; Glenn Liu; Kyle Holen; Garry Schwartz; Mark Albertini; Geoffrey Weiss; Salim Yazji; Chee Ng; George Wilding
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

10.  TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase.

Authors:  Jie Fan; Randall S Frey; Asrar B Malik
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.